サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1291582

リキッドバイオプシー市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Liquid Biopsy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
リキッドバイオプシー市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のリキッドバイオプシー市場規模は、2022年に18億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に15.3%の成長率（CAGR）を示し、2028年までに43億米ドルに達すると予測しています。

リキッドバイオプシーは、外科的生検に代わる非侵襲的な方法であり、医師が血液サンプルを通じて腫瘍に関する情報を入手し、それに基づいて治療計画を立てることができます。腫瘍の遺伝子発現プロファイルの変化を反映することができ、個別化治療のための強固な基盤を提供することができます。早期診断のスクリーニング、腫瘍の不均一性、薬剤耐性に役立ちます。これに加えて、非小細胞肺がん（NSCLC）患者の間で発生する上皮成長因子受容体（EGFR）遺伝子変異を検出することもできます。

リキッドバイオプシーの市場動向：

座りがちな生活習慣やタバコの消費量の増加により、世界中でがん患者の数が急増しています。このことは、がん診断における高度な低侵襲（MI）治療に対する個人の意識の高まりとともに、市場を牽引する重要な要因の1つとなっています。さらに、先進的ながんソリューションの導入を促進するため、各国の行政当局が研究開発活動に資金を提供しています。また、これらの当局は、ヘルスケア産業の発展に多大な投資を行っており、業界関係者に有利な成長機会を提供しています。これとは別に、主な市場参入企業は、世界中で個別化医療を発展させるために製品の発売を重視しています。また、リキッドバイオプシーの技術的進歩を統合し、より良い手順のワークフローとアウトプットを提供しようとしています。これは、腫瘍の早期発見のための血液ベースの生検検査の採用が増加していることと相まって、市場にプラスの影響を及ぼしています。さらに、高い精度と処置時間の短縮を実現するために、エクソソームを腫瘍学の臨床診断に使用するケースが増えていることも、リキッドバイオプシーの需要を喚起しています。市場開拓の要因として、デジタルポリメラーゼ連鎖反応（PCR）および次世代シーケンサー（NGS）ベースの技術の急速な発展が予測されます。

本レポートで回答した主な質問

  • リキッドバイオプシーの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19は世界のリキッドバイオプシー市場にどのような影響を与えたか？
  • 主要な地域市場とは？
  • 製品・サービスに基づく市場の内訳は？
  • 循環型バイオマーカーに基づく市場の内訳は？
  • がん種に基づく市場内訳は？
  • 最終用途に基づく市場の内訳は？
  • 業界のバリューチェーンにおける様々なステージは何か？
  • 業界における主要な促進要因と課題は何か？
  • 世界のリキッドバイオプシー市場の構造と主要企業は？
  • 業界の競合の程度はどの程度か？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 リキッドバイオプシーの世界市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 製品・サービス別市場内訳

  • キット・試薬
    • 市場動向
    • 市場予測
  • プラットフォームとインストゥルメント
    • 市場動向
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測

第7章 循環型バイオマーカー別市場内訳

  • 循環腫瘍細胞
    • 市場動向
    • 市場予測
  • 細胞外小胞
    • 市場動向
    • 市場予測
  • 循環腫瘍DNA
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 がんタイプ別市場内訳

  • 肺がん
    • 市場動向
    • 市場予測
  • 乳がん
    • 市場動向
    • 市場予測
  • 大腸がん
    • 市場動向
    • 市場予測
  • 前立腺がん
    • 市場動向
    • 市場予測
  • 肝臓がん
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 最終用途別市場内訳

  • 病院、研究所
    • 市場動向
    • 市場予測
  • 学術・研究センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • ANGLE plc
    • Biocept Inc.
    • Bio-Rad Laboratories Inc
    • Epigenomics AG
    • Exact Sciences Corporation
    • F.Hoffmann-La Roche AG
    • Guardant Health Inc.
    • Illumina Inc.
    • MDxHealth SA
    • Menarini Silicon Biosystems
    • QIAGEN N.V.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Liquid Biopsy Market: Major Drivers and Challenges
  • Figure 2: Global: Liquid Biopsy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Liquid Biopsy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Liquid Biopsy Market: Breakup by Product and Service (in %), 2022
  • Figure 5: Global: Liquid Biopsy Market: Breakup by Circulating Biomarker (in %), 2022
  • Figure 6: Global: Liquid Biopsy Market: Breakup by Cancer Type (in %), 2022
  • Figure 7: Global: Liquid Biopsy Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Liquid Biopsy Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Liquid Biopsy (Kits and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Liquid Biopsy (Kits and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Liquid Biopsy (Platforms and Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Liquid Biopsy (Platforms and Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Liquid Biopsy (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Liquid Biopsy (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Liquid Biopsy (Circulating Tumor Cells) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Liquid Biopsy (Circulating Tumor Cells) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Liquid Biopsy (Extracellular Vesicles) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Liquid Biopsy (Extracellular Vesicles) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Liquid Biopsy (Circulating Tumor DNA) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Liquid Biopsy (Circulating Tumor DNA) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Liquid Biopsy (Other Circulating Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Liquid Biopsy (Other Circulating Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Liquid Biopsy (Lung Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Liquid Biopsy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Liquid Biopsy (Breast Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Liquid Biopsy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Liquid Biopsy (Colorectal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Liquid Biopsy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Liquid Biopsy (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Liquid Biopsy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Liquid Biopsy (Liver Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Liquid Biopsy (Liver Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Liquid Biopsy (Other Cancer Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Liquid Biopsy (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Liquid Biopsy (Hospitals and Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Liquid Biopsy (Hospitals and Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Liquid Biopsy (Academic and Research Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Liquid Biopsy (Academic and Research Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Liquid Biopsy (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Liquid Biopsy (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: North America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: North America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: United States: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: United States: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Canada: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Canada: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Asia-Pacific: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Asia-Pacific: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: China: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: China: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Japan: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Japan: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: India: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: India: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: South Korea: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: South Korea: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Australia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Australia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Indonesia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Indonesia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Europe: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Europe: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Germany: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Germany: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: France: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: France: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: United Kingdom: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: United Kingdom: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Italy: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Italy: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Spain: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Spain: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Russia: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Russia: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Latin America: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Latin America: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Brazil: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Brazil: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Mexico: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Mexico: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Others: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Others: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Middle East and Africa: Liquid Biopsy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Middle East and Africa: Liquid Biopsy Market: Breakup by Country (in %), 2022
  • Figure 89: Middle East and Africa: Liquid Biopsy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Global: Liquid Biopsy Industry: SWOT Analysis
  • Figure 91: Global: Liquid Biopsy Industry: Value Chain Analysis
  • Figure 92: Global: Liquid Biopsy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Liquid Biopsy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Liquid Biopsy Market Forecast: Breakup by Product and Service (in Million US$), 2023-2028
  • Table 3: Global: Liquid Biopsy Market Forecast: Breakup by Circulating Biomarker (in Million US$), 2023-2028
  • Table 4: Global: Liquid Biopsy Market Forecast: Breakup by Cancer Type (in Million US$), 2023-2028
  • Table 5: Global: Liquid Biopsy Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Liquid Biopsy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Liquid Biopsy Market: Competitive Structure
  • Table 8: Global: Liquid Biopsy Market: Key Players
目次
Product Code: SR112023A5125

The global liquid biopsy market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 15.3% during 2023-2028.

Liquid biopsy is a non-invasive alternative to surgical biopsies enabling doctors to obtain information about a tumor through a blood sample and plan the treatment accordingly. It can reflect changes in tumor gene expression profile and offer a robust base for individualized therapy. It assists in the early diagnosis screening, tumor heterogeneity and drug resistance. Besides this, it also detects epidermal growth factor receptor (EGFR) gene mutations, which occur among patients with non-small cell lung cancer (NSCLC).

Liquid Biopsy Market Trends:

Due to sedentary lifestyles and rising tobacco consumption, there is a surge in the number of cancer patients across the globe. This, along with the growing awareness among individuals about advanced minimally invasive (MI) procedures in cancer diagnostics, represents one of the key factors driving the market. Moreover, governing authorities of several countries are financing research and development (R&D) activities to encourage the introduction of advanced cancer solutions. These authorities are also considerable investing in the development of the healthcare industry, which is offering lucrative growth opportunities to industry players. Apart from this, key market players are focusing on product launches to develop personalized medicine worldwide. They are also integrating technological advancements in liquid biopsy to offer better procedure workflow and output. This, coupled with the rising adoption of blood-based biopsy tests for early tumor detection, is positively influencing the market. Additionally, the increasing usage of exosomes for clinical diagnosis in oncology to provide high accuracy and reduced procedural time is catalyzing the demand for liquid biopsy. Growth-inducing factors projected to impel the market growth are rapid development in digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) based technology.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid biopsy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, circulating biomarker, cancer type and end user.

Breakup by Product and Service:

Kits and Reagents

Platforms and Instruments

Services

Breakup by Circulating Biomarker:

Circulating Tumor Cells

Extracellular Vesicles

Circulating Tumor DNA

Others

Breakup by Cancer Type:

Lung Cancer

Breast Cancer

Colorectal Cancer

Prostate Cancer

Liver Cancer

Others

Breakup by End User:

Hospitals and Laboratories

Academic and Research Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc, Epigenomics AG, Exact Sciences Corporation, F. Hoffmann-La Roche AG, Guardant Health Inc., Illumina Inc., MDxHealth SA, Menarini Silicon Biosystems, QIAGEN N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global liquid biopsy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global liquid biopsy market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product and service?
  • What is the breakup of the market based on the circulating biomarker?
  • What is the breakup of the market based on the cancer type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global liquid biopsy market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Liquid Biopsy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product and Service

  • 6.1 Kits and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Platforms and Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Circulating Biomarker

  • 7.1 Circulating Tumor Cells
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Extracellular Vesicles
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Circulating Tumor DNA
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Cancer Type

  • 8.1 Lung Cancer
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Breast Cancer
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Colorectal Cancer
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Prostate Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Liver Cancer
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Others
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 ANGLE plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Biocept Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 Bio-Rad Laboratories Inc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Epigenomics AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Exact Sciences Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F.Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Guardant Health Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Illumina Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 MDxHealth SA
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Menarini Silicon Biosystems
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 QIAGEN N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis